首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Reduced striatal D2 receptor binding in myoclonus-dystonia.
【24h】

Reduced striatal D2 receptor binding in myoclonus-dystonia.

机译:肌阵挛性肌张力障碍中纹状体D2受体结合减少。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To study striatal dopamine D(2) receptor availability in DYT11 mutation carriers of the autosomal dominantly inherited disorder myoclonus-dystonia (M-D). METHODS: Fifteen DYT11 mutation carriers (11 clinically affected) and 15 age- and sex-matched controls were studied using (123)I-IBZM SPECT. Specific striatal binding ratios were calculated using standard templates for striatum and occipital areas. RESULTS: Multivariate analysis with corrections for ageing and smoking showed significantly lower specific striatal to occipital IBZM uptake ratios (SORs) both in the left and right striatum in clinically affected patients and also in all DYT11 mutation carriers compared to control subjects. CONCLUSIONS: Our findings are consistent with the theory of reduced dopamine D(2) receptor (D2R) availability in dystonia, although the possibility of increased endogenous dopamine, and consequently, competitive D2R occupancy cannot be ruled out.
机译:目的:研究常染色体显性遗传性肌阵挛性肌张力障碍(M-D)的DYT11突变携带者中的纹状体多巴胺D(2)受体的可用性。方法:使用(123)I-IBZM SPECT研究了15个DYT11突变携带者(11个临床受影响)和15个年龄和性别匹配的对照。使用纹状体和枕叶区域的标准模板计算特定的纹状体结合率。结果:对年龄和吸烟进行校正的多变量分析显示,与对照组相比,临床受影响患者以及所有DYT11突变携带者的左右纹状体的特定纹状体至枕骨IBZM摄取率(SOR)均显着降低。结论:我们的发现与肌张力障碍中降低多巴胺D(2)受体(D2R)可用性的理论相符,尽管不能排除内源性多巴胺增加的可能性,因此不能排除竞争性D2R占用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号